SAN FRANCISCO -- Another COVID-19 vaccine -- AstraZeneca -- is poised to arrive in the U.S., bringing a fourth option for Americans. Each vaccine is administered slightly differently, some can result ...
Nov 23 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, giving the world another ...
In response to a call from President Donald Trump to make the positive impact of Covid-19 vaccines public, drug giant Pfizer posted a collection of more than 200 news releases and statements and 27 ...
The Trump administration is canceling numerous contracts and pharmaceutical proposals advancing mRNA vaccine research, officials announced Tuesday night. Health and Human Services Secretary Robert F.
Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu ...
The U.S. Food and Drug Administration (FDA) may not renew the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine for children under the age of five, the company said. The possible ...
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback